Debut Plus

₹182.75

▲ +2.31 +1.28%

17 Jul 2026

NSE Listed

ESM 1

Kilitch Drugs India Ltd. (KILITCH)

Volume: 18,698Avg Vol 1W: 31,536.4Avg Vol 1M: 74,787.752W Range:₹117.25₹227.23
NSE BSE www.kilitch.com
Key Ratios
Checked just now
Market Cap₹639 Cr
Current Price₹182.75
Previous Close₹180.44
High / Low (52w)₹227.23 / ₹117.25
Volume18,698
Avg Vol (1W)31,536.4
Avg Vol (1M)74,787.7
Stock P/E43.1
Book Value₹79.99
Dividend Yield0%
ROE10.79%
ROA6.44%
Revenue (TTM)₹209 Cr
Revenue Growth28.5%
Profit Margin12.81%
Total Debt₹28 Cr
Shares Outstanding3 Cr
Face Value₹10
EPS (TTM)₹8.63
P/B2.27
Debt / Equity0.21
50 DMA₹183.43
200 DMA₹170.47
Day change+1.28%
SurveillanceESM 1 (as of 2026-07-13)
Price Chart
₹182.75▼ 18.81% · 1Y
₹225₹12417.6L
2025-07-17
2026-07-16

20-day avg volume: 75K shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Cons
  • Revenue fell 38% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹33 Cr₹47 Cr₹56 Cr₹61 Cr₹43 Cr₹49 Cr₹54 Cr₹90 Cr
EBITDA₹3 Cr₹11 Cr₹10 Cr₹15 Cr₹5 Cr₹11 Cr₹7 Cr₹22 Cr
Net Profit₹1 Cr₹9 Cr₹6 Cr₹10 Cr₹3 Cr₹8 Cr₹4 Cr₹15 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹54 Cr₹86 Cr₹57 Cr₹71 Cr₹117 Cr₹143 Cr₹159 Cr₹209 Cr
EBITDA₹6 Cr₹9 Cr₹2 Cr₹6 Cr₹11 Cr₹17 Cr₹25 Cr₹40 Cr
Net Profit₹5 Cr₹4 Cr₹1 Cr₹4 Cr₹7 Cr₹10 Cr₹15 Cr₹27 Cr
EPS3.662.610.552.434.736.719.1716.6
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹128 Cr₹144 Cr₹143 Cr₹203 Cr₹210 Cr₹220 Cr₹240 Cr₹313 Cr
Total Liabilities₹15 Cr₹21 Cr₹22 Cr₹74 Cr₹70 Cr₹69 Cr₹64 Cr₹112 Cr
Equity₹113 Cr₹123 Cr₹120 Cr₹129 Cr₹140 Cr₹151 Cr₹176 Cr₹200 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹1 Cr₹4 Cr₹7 Cr₹47 Cr₹8 Cr₹7 Cr₹6 Cr₹26 Cr
Investing₹-4 Cr₹-14 Cr₹-10 Cr₹-38 Cr₹-15 Cr₹8 Cr₹-8 Cr₹-40 Cr
Financing₹6 Cr₹17 Cr₹1 Cr₹2 Cr₹7 Cr₹-1 Cr₹9 Cr₹13 Cr
Free Cash Flow₹1 Cr₹4 Cr₹7 Cr₹47 Cr₹8 Cr₹7 Cr₹6 Cr₹26 Cr
Shareholding
Promoter 63.77% Institutions 0.12% Public 36.11%
Efficiency & Working Capital
ROCE12%
Interest Coverage6.7
Dividend Payout—
Debtor Days156 d
Inventory Days28 d
Payable Days100 d
Cash Conversion Cycle84 d
Working Capital Days184 d
Shareholding Details

As of 2026-06-30

Promoter63.8%
FII0.1%
DII0%
Institutions0.1%
Public36.1%
Promoter Pledge0%
No. of Shareholders12,627
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%63.8%63.8%63.8%63.8%
FIIs0%0%0%0%0%0%0%0%0%0%0%0.1%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%36.2%36.2%36.2%36.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders9,0029,0629,5259,6209,92010,1399,74910,37910,92912,04311,78512,627
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Kilitch Company (pharma) LimitedShareholding of Promoter and Promoter Group37.9%1.33 Cr
Bhavin Mukund MehtaShareholding of Promoter and Promoter Group14.4%50,46,276
Mukund MehtaShareholding of Promoter and Promoter Group6.6%23,09,294
Mira Bhavin MehtaShareholding of Promoter and Promoter Group4.8%16,82,092
Dipak Kanayalal ShahPublic Shareholding3.2%11,20,000
Mukul Mahavir AgrawalPublic Shareholding1.3%4,70,000
Premilaben Rameshchandra ShahPublic Shareholding1.1%4,00,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Bhavin Mukund Mehta00%2026-06-30
Mukund Mehta00%2026-06-30
Mira Bhavin Mehta00%2026-06-30
Kilitch Company (pharma) Limited00%2026-06-30
Dipak Kanayalal Shah00%2026-06-30
Mukul Mahavir Agrawal00%2026-06-30
Premilaben Rameshchandra Shah00%2026-06-30
Bhavin Mukund Mehta00%2026-03-31
Mukund Mehta00%2026-03-31
Mira Bhavin Mehta00%2026-03-31
Kilitch Company (pharma) Limited00%2026-03-31
Dipak Kanayalal Shah00%2026-03-31
Board of Directors
NameDesignationYear
Mukund P MehtaChairman & Managing Director2025
Bhavin M MehtaWTD & Executive Director2025
Mira MehtaManaging Director2025
VASUDEV KRISHNAMURTIIndependent Non Exe. Director2025
Venkita Subramanian RajanIndependent Non Exe. Director2025
DIPEN JAYANTILAL JAINIndependent Non Exe. Director2025
Pushpa NyoupaneCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
development and operations of Pharm₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10251616
Corporate Actions
TypeDateValueRemark
bonus2026-03-241:11:1 Bonus Issue of Equity Shares
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20253002067
20253000063
2025000202
Insider / Designated-Person Trades

5 recent disclosure(s)

Mira Bhavin MehtaAcquisition · 8,41,046
Bhavin Mukund MehtaDisposal · 8,41,046
Bhavin Mukund MehtaAcquisition · 11,11,768
Mukund MehtaDisposal · 11,11,768
Mukund MehtaAcquisition · 11,11,768
Substantial Acquisitions (SAST)

4 disclosure(s)

-23/08/2024 · 8,41,046
Inter-se Transfer23/08/2024 · 8,41,046
Inter-se Transfer23/08/2024 · 8,41,046
NULL23/08/2024 · 8,41,046
Company Information
Incorporated1992
ChairmanMukund P Mehta
AuditorSuryaprakash Maurya & Co/C Sharat & Associates
Investor Email[email protected]
🌐 www.kilitch.com ↗

📍 C-301/2 MIDC TTC Indl Area, Pawane Village, Thane, Maharashtra, 400705

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Khadim India LimitedKhaitan Chem & Fert Ltd.Khaitan (India)Ltd.Khandwala Securities Ltd.KHFM Hos Fac Mana Ser Ltd.Kalyani Invest Co Ltd.Krishna Inst of Med Sci LimitedKingfa Sci & Tec Ind Ltd.KIOCL LimitedKiran Vyapar Ltd.Kiri Industries LimitedKirloskar Ferrous Ind Ltd.All “K” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search